Acute polyradiculoneuritis: Guillain-Barré syndrome

Handbook of Clinical Neurology

Volumn 112, Issue , 2013, Pages 1157-1162

  Korinthenberg, Rudolf ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84876794466     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-52910-7.00036-2     Document Type: Chapter

References (38)

1. Asbury A.K. New concepts of Guillain-Barré syndrome. J Child Neurol 2000, 15:183-191.
2. Asbury A.K., Cornblath D.R. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990, 27:S21-S24.
3. Chiba A., Kusunoki S., Obata H., et al. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology 1993, 43:1911-1917.
4. Delanoe C., Sebire G., Landrieu P., et al. Acute inflammatory demyelinating polyradiculoneuropathy in children: clinical and electrodiagnostic studies. Ann Neurol 1998, 44:350-356.
5. Epstein M.A., Sladky J.T. The role of plasmapheresis in childhood Guillain-Barré syndrome. Ann Neurol 1990, 28:65-69.
6. Gürses N., Uysal S., Cetinkaya F., et al. Intravenous immunoglobulin treatment in children with Guillain-Barre syndrome. Scand J Infect Dis 1995, 27:241-243.
7. Haber P., Sejvar J., Mukaeloff Y., et al. Vaccines and Guillain-Barré syndrome. Drug Saf 2009, 32:309-323.
8. Hadden R.D., Karch H., Hartung H.P., et al. Preceding infections, immune factors, and outcome in Guillain-Barre syndrome. Neurology 2001, 56:758-765.
9. Hughes R.A., Rees J., Smeeton N., et al. Vaccines and Guillain-Barre syndrome. Br Med J 1996, 312:1475-1476.
10. Hughes R.A., Cornblath D.R. Guillain-Barre syndrome. Lancet 2005, 366:1653-1666.
11. Hughes R.A., Raphael J.C., Swan A., et al. Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane Database Syst Rev 2006, 7. CD002063.
12. Jacobs B.C., Rothbarth P.H., van der Meche F., et al. The spectrum of antecedent infections in Guillain-Barre syndrome: a case-control study. Neurology 1998, 51:1110-1115.
13. Korinthenberg R., Schulte-Mönting J. Natural history and treatment effects in Guillain-Barre syndrome: a multicentre study. Arch Dis Child 1996, 74:281-287.
14. Korinthenberg R., Schessl J., Kirschner J., et al. Intravenously administered immunoglobulin in the treatment of childhood Guillain-Barre syndrome: a randomized trial. Pediatrics 2005, 116:8-14.
15. Korinthenberg R., Schessl J., Kirschner J. Clinical presentation and course of childhood Guillain-Barré syndrome: a prospective multicentre study. Neuropediatrics 2007, 38:10-17.
16. Kuitwaard K., van Koningsveld R., Ruts L., et al. Recurrent Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 2009, 80:56-59.
17. Martens-Le Bouar H., Korinthenberg R. Polyradiculoneuritis with myelitis: a rare differential diagnosis of Guillain-Barré syndrome. Neuropediatrics 2002, 33:93-96.
18. McGrogan A., Madle G.C., Seaman H.E., et al. The epidemiology of Guillain-Barre syndrome worldwide. a systematic literature review. Neuroepidemiology 2008, 32:150-163.
19. Nachamkin I., Barbosa P.A., Ung H., et al. Patterns of Guillain-Barre syndrome in children: results from a Mexican population. Neurology 2007, 69:1665-1671.
20. PE/Sandoglobulin GBS Trial Group Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barre syndrome. Plasma Exchange/Sandoglobulin Guillain-Barre Syndrome Trial Group. Lancet 1997, 349:225-230.
21. Paradiso G., Tripoli J., Galicchio S., et al. Epidemiological, clinical, and electrodiagnostic findings in childhood Guillain-Barré syndrome: a reappraisal. Ann Neurol 1999, 46:701-707.
22. Patja A., Paunio M., Kinnunen E., et al. Risk of Guillain-Barre syndrome after measles-mumps-rubella vaccination. J Pediatr 2001, 138:250-254.
23. Raphaël J.C., Chevret S., Hughes R.A., et al. Plasma exchange for Guillain-Barré syndrome. Cochrane Database Syst Rev. 2012 Jul 11, 7:CD001798. 10.1002/14651858.CD001798.pub2.
24. Ruts L., van Koningsveld R., van Doorn P.A. Distinguishing acute-onset CIDP from Guillain-Barré syndrome with treatment related fluctuations. Neurology 2005, 65:138-140.
25. Schessl J., Luther B., Kirschner J., et al. Infections and vaccinations preceding childhood Guillain-Barré syndrome: a prospective study. Eur J Pediatr 2006, 165:605-612.
26. Shahrizaila N., Yuki N. Guillain-Barré syndrome animal model: the first proof of molecular mimicry in human autoimmune disorder. J Biomed Biotechnol 2011, 10.1155/2011/829129.
27. Sladky J.T. Guillain-Barre syndrome in children. J Child Neurol 2004, 19:191-200.
28. Souayah N., Nasar A., Suri M.F., et al. Guillain-Barré syndrome after vaccination in United States: data from the Centers for Disease Control and Prevention/Food and Drug Administration Vaccine Adverse Event Reporting System (1990-2005). J Clin Neuromuscul Dis 2009, 11:1-6.
29. Tekgul H., Serdaroglu G., Tutuncuoglu S. Outcome of axonal and demyelinating forms of Guillain-Barre syndrome in children. Pediatr Neurol 2003, 28:295-299.
30. Vajsar J., Fehlings D., Stephens D. Long-term outcome in children with Guillain-Barré syndrome. J Pediatr 2003, 142:305-309.
31. van der Meche F.G., Schmitz P.I. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barre syndrome. Dutch Guillain-Barre Study Group. N Engl J Med 1992, 326:1123-1129.
32. van Doorn P.A., Kuitwaard K., Walgaard C., et al. IVIG treatment and prognosis in Guillain-Barré syndrome. J Clin Immunol 2010, 30:S74-S78.
33. Walgaard C., Lingsma H.F., Ruts L., et al. Early recognition of poor prognosis in Guillain-Barré syndrome. Neurology 2011, 76:968-975.
34. Willison H.J., Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain 2002, 125:2591-2625.
35. Winer J.B., Hughes R.A., Anderson M.J., et al. A prospective study of acute idiopathic neuropathy. II. Antecedent events. J Neurol Neurosurg Psychiatry 1988, 51:613-618.
36. Wu H.S., Liu T.C., Lu Z.L., et al. A prospective clinical and electrophysiologic survey of acute flaccid paralysis in Chinese children. Neurology 1997, 49:1723-1725.
37. Yata J., Nihei K., Ohya T., et al. High-dose immunoglobulin therapy for Guillain-Barre syndrome in Japanese children. Pediatr Int 2003, 45:543-549.
38. Yuki N. Infectious origins of, and molecular mimicry in, Guillain-Barré and Fisher syndromes. Lancet Infect Dis 2001, 1:29-37.